HEADER COMPLEX (RECEPTOR/IMMUNOGLOBULIN) 11-NOV-94 1FRT TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC CAVEAT 1FRT FUC E 9 HAS WRONG CHIRALITY AT ATOM C1 FUC E 9 HAS WRONG CAVEAT 2 1FRT CHIRALITY AT ATOM C5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEONATAL FC RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA 2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: IGG FC; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 ORGAN: SERUM (MIXTURE OF SEVERAL SUBTYPES); SOURCE 6 GENE: BETA-2-MICROGLOBULIN; SOURCE 7 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBJ5-GS; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 14 ORGANISM_COMMON: NORWAY RAT; SOURCE 15 ORGANISM_TAXID: 10116; SOURCE 16 ORGAN: SERUM (MIXTURE OF SEVERAL SUBTYPES); SOURCE 17 GENE: BETA-2-MICROGLOBULIN; SOURCE 18 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 19 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 21 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PBJ5-GS; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 25 ORGANISM_COMMON: NORWAY RAT; SOURCE 26 ORGANISM_TAXID: 10116; SOURCE 27 ORGAN: SERUM (MIXTURE OF SEVERAL SUBTYPES); SOURCE 28 GENE: BETA-2-MICROGLOBULIN; SOURCE 29 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 30 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 31 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 32 EXPRESSION_SYSTEM_CELL_LINE: CHO; SOURCE 33 EXPRESSION_SYSTEM_PLASMID: PBJ5-GS KEYWDS COMPLEX (RECEPTOR-IMMUNOGLOBULIN), COMPLEX (RECEPTOR-IMMUNOGLOBULIN) KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.P.BURMEISTER,P.J.BJORKMAN REVDAT 6 29-JUL-20 1FRT 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 05-FEB-20 1FRT 1 CAVEAT REMARK SEQADV LINK REVDAT 4 13-JUL-11 1FRT 1 VERSN REVDAT 3 24-FEB-09 1FRT 1 VERSN REVDAT 2 15-MAY-95 1FRT 1 SOURCE REMARK REVDAT 1 14-FEB-95 1FRT 0 JRNL AUTH W.P.BURMEISTER,A.H.HUBER,P.J.BJORKMAN JRNL TITL CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR JRNL TITL 2 WITH FC. JRNL REF NATURE V. 372 379 1994 JRNL REFN ISSN 0028-0836 JRNL PMID 7969498 JRNL DOI 10.1038/372379A0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.P.BURMEISTER,L.N.GASTINEL,N.E.SIMISTER,M.L.BLUM, REMARK 1 AUTH 2 P.J.BJORKMAN REMARK 1 TITL CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF THE REMARK 1 TITL 2 MHC-RELATED NEONATAL FC RECEPTOR REMARK 1 REF NATURE V. 372 336 1994 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.RAGHAVAN,M.Y.CHEN,L.N.GASTINEL,P.J.BJORKMAN REMARK 1 TITL INVESTIGATION OF THE INTERACTION BETWEEN THE CLASS I REMARK 1 TITL 2 MHC-RELATED FC RECEPTOR AND ITS IMMUNOGLOBULIN G LIGAND REMARK 1 REF IMMUNITY V. 1 303 1994 REMARK 1 REFN ISSN 1074-7613 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.H.HUBER,R.F.KELLY,L.N.GASTINEL,P.J.BJORKMAN REMARK 1 TITL CRYSTALLIZATION AND STOICHIOMETRY OF BINDING OF A COMPLEX REMARK 1 TITL 2 BETWEEN A RAT INTESTINAL FC RECEPTOR AND FC REMARK 1 REF J.MOL.BIOL. V. 230 1077 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DEISENHOFER REMARK 1 TITL CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC REMARK 1 TITL 2 FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM REMARK 1 TITL 3 STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION REMARK 1 REF BIOCHEMISTRY V. 20 2361 1981 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 4.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 67.0 REMARK 3 NUMBER OF REFLECTIONS : 8433 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.423 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4608 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 199.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FRT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173395. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8527 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 67.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 62.50000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 108.25000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 72.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 108.25000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 62.50000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 72.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 62.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.50000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 108.25000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.50000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 62.50000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 108.25000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MTRIX REMARK 300 THE INFORMATION PRESENTED ON SYMMETRY RECORDS BELOW REMARK 300 DESCRIBE TRANSFORMATIONS TO GENERATE CRYSTALLOGRAPHIC REMARK 300 RELATIONSHIPS AS DESCRIBED IN THE STATEMENT THAT FOLLOWS REMARK 300 EACH SYMMETRY OPERATOR. REMARK 300 REMARK 300 APPLIED TO TRANSFORMED TO REMARK 300 MTRIX CHAIN RESIDUES CHAIN RESIDUES RMSD REMARK 300 S1 C 1 - C 443 ? 1 - ? 443 REMARK 300 REMARK 300 THIS TRANSFORMATION GENERATES THE SECOND CHAIN OF THE FC REMARK 300 MOLECULE. IF THE SAME OPERATION IS ALSO APPLIED TO THE REMARK 300 FCRN MOLECULE, THE "STANDING UP" FCRNFC COMPLEX REMARK 300 DISCUSSED IN THE ACCOMPANYING PAPER IS GENERATED. REMARK 300 REMARK 300 S2 A 1 - A 405 ? 1 - ? 405 REMARK 300 S2 B 1 - B 99 ? 1 - ? 99 REMARK 300 REMARK 300 THIS TRANSFORMATION GENERATES THE SECOND SUBUNIT FOR THE REMARK 300 "LYING DOWN" FC RECEPTOR DIMER PRESENTED IN THE REMARK 300 ACCOMPANYING PAPER. REMARK 300 REMARK 300 SYMMETRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 300 SYMMETRY2 1 0.000000 -1.000000 0.000000 145.00000 REMARK 300 SYMMETRY3 1 0.000000 0.000000 -1.000000 108.25000 REMARK 300 SYMMETRY1 2 -1.000000 0.000000 0.000000 250.00000 REMARK 300 SYMMETRY2 2 0.000000 -1.000000 0.000000 72.50000 REMARK 300 SYMMETRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 145.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 108.25000 REMARK 450 REMARK 450 SOURCE REMARK 450 SOURCE 1 REMARK 450 MOLECULE_NAME: FC (IGG) RECEPTOR, NEONATAL (FCRN) THE REMARK 450 CELL LINE SECRETES A SOLUBLE FCRN HETERODIMER COMPOSED REMARK 450 OF THE EXTRACELLULAR DOMAINS OF THE RAT FCRN HEAVY CHAIN REMARK 450 ASSOCIATED WITH RAT BETA-2-MICROGLOBULIN. REMARK 450 SOURCE 2 REMARK 450 MOLECULE_NAME: FC FRAGMENT (IGG) OBTAINED FROM JACKSON REMARK 450 IMMUNORESEARCH LABS. THE FC FRAGMENT IS A MIXTURE OF REMARK 450 SUBTYPES 1, 2A, 2B, AND 2C. THE N-TERMINUS IS NOT REMARK 450 PRECISELY KNOWN, BUT THE CLEAVAGE SITE IS C-TERMINAL TO REMARK 450 THE DISULFIDE BONDS OF THE HINGE REGION. THE FRAGMENT IS, REMARK 450 THEREFORE, A NON-COVALENT DIMER. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: B1A REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR FC ON FCRN REMARK 800 REMARK 800 SITE_IDENTIFIER: B2A REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: POSSIBLE BINDING SITE FOR FC ON THE SECOND REMARK 800 MOLECULE OF THE FCRN DIMER REMARK 800 REMARK 800 SITE_IDENTIFIER: B1B REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR FCRN ON FC REMARK 800 REMARK 800 SITE_IDENTIFIER: B2B REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: POSSIBLE BINDING SITE FOR FCRN ASSUMING THE REMARK 800 PRESENCE OF THE FCRN DIMER REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE ARE A NUMBER OF CLOSE CONTACTS BETWEEN ATOMS IN THIS REMARK 999 THIS MOLECULE AND IN SYMMETRY-RELATED MOLECULES. DBREF 1FRT A 1 269 UNP P13599 FCGN_RAT 23 291 DBREF 1FRT B 1 99 UNP P07151 B2MG_RAT 21 119 DBREF 1FRT C 239 443 GB 243866 AAB21181 262 466 SEQADV 1FRT GLN C 272 GB 243866 GLU 295 CONFLICT SEQADV 1FRT GLN C 283 GB 243866 GLU 306 CONFLICT SEQADV 1FRT GLN C 294 GB 243866 GLU 317 CONFLICT SEQADV 1FRT ASN C 312 GB 243866 ASP 335 CONFLICT SEQADV 1FRT ASP C 315 GB 243866 ASN 338 CONFLICT SEQADV 1FRT GLU C 356 GB 243866 ASP 379 CONFLICT SEQADV 1FRT MET C 358 GB 243866 LEU 381 CONFLICT SEQRES 1 A 269 ALA GLU PRO ARG LEU PRO LEU MET TYR HIS LEU ALA ALA SEQRES 2 A 269 VAL SER ASP LEU SER THR GLY LEU PRO SER PHE TRP ALA SEQRES 3 A 269 THR GLY TRP LEU GLY ALA GLN GLN TYR LEU THR TYR ASN SEQRES 4 A 269 ASN LEU ARG GLN GLU ALA ASP PRO CYS GLY ALA TRP ILE SEQRES 5 A 269 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 A 269 THR ASP LEU LYS SER LYS GLU GLN LEU PHE LEU GLU ALA SEQRES 7 A 269 ILE ARG THR LEU GLU ASN GLN ILE ASN GLY THR PHE THR SEQRES 8 A 269 LEU GLN GLY LEU LEU GLY CYS GLU LEU ALA PRO ASP ASN SEQRES 9 A 269 SER SER LEU PRO THR ALA VAL PHE ALA LEU ASN GLY GLU SEQRES 10 A 269 GLU PHE MET ARG PHE ASN PRO ARG THR GLY ASN TRP SER SEQRES 11 A 269 GLY GLU TRP PRO GLU THR ASP ILE VAL GLY ASN LEU TRP SEQRES 12 A 269 MET LYS GLN PRO GLU ALA ALA ARG LYS GLU SER GLU PHE SEQRES 13 A 269 LEU LEU THR SER CYS PRO GLU ARG LEU LEU GLY HIS LEU SEQRES 14 A 269 GLU ARG GLY ARG GLN ASN LEU GLU TRP LYS GLU PRO PRO SEQRES 15 A 269 SER MET ARG LEU LYS ALA ARG PRO GLY ASN SER GLY SER SEQRES 16 A 269 SER VAL LEU THR CYS ALA ALA PHE SER PHE TYR PRO PRO SEQRES 17 A 269 GLU LEU LYS PHE ARG PHE LEU ARG ASN GLY LEU ALA SER SEQRES 18 A 269 GLY SER GLY ASN CYS SER THR GLY PRO ASN GLY ASP GLY SEQRES 19 A 269 SER PHE HIS ALA TRP SER LEU LEU GLU VAL LYS ARG GLY SEQRES 20 A 269 ASP GLU HIS HIS TYR GLN CYS GLN VAL GLU HIS GLU GLY SEQRES 21 A 269 LEU ALA GLN PRO LEU THR VAL ASP LEU SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLN PHE HIS PRO PRO GLN ILE GLU ILE GLU LEU SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO ASN ILE GLU MET SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP VAL TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS VAL THR LEU LYS GLU PRO LYS SEQRES 8 B 99 THR VAL THR TRP ASP ARG ASP MET SEQRES 1 C 205 SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP THR LEU SEQRES 2 C 205 MET ILE SER ARG THR PRO GLU VAL THR CYS VAL VAL VAL SEQRES 3 C 205 ASP VAL SER HIS GLU ASP PRO GLN VAL LYS PHE ASN TRP SEQRES 4 C 205 TYR VAL ASP GLY VAL GLN VAL HIS ASN ALA LYS THR LYS SEQRES 5 C 205 PRO ARG GLU GLN GLN TYR ASN SER THR TYR ARG VAL VAL SEQRES 6 C 205 SER VAL LEU THR VAL LEU HIS GLN ASN TRP LEU ASP GLY SEQRES 7 C 205 LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA LEU PRO SEQRES 8 C 205 ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS GLY GLN SEQRES 9 C 205 PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SER ARG SEQRES 10 C 205 GLU GLU MET THR LYS ASN GLN VAL SER LEU THR CYS LEU SEQRES 11 C 205 VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL GLU TRP SEQRES 12 C 205 GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS THR THR SEQRES 13 C 205 PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE LEU TYR SEQRES 14 C 205 SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN GLN GLY SEQRES 15 C 205 ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA LEU HIS SEQRES 16 C 205 ASN HIS TYR THR GLN LYS SER LEU SER LEU MODRES 1FRT ASN A 104 ASN GLYCOSYLATION SITE MODRES 1FRT ASN A 225 ASN GLYCOSYLATION SITE MODRES 1FRT ASN C 297 ASN GLYCOSYLATION SITE HET NAG D 1 14 HET FUC D 2 10 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET NAG E 5 14 HET GAL E 6 11 HET MAN E 7 11 HET NAG E 8 14 HET FUC E 9 10 HET NAG A 401 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE FORMUL 4 NAG 6(C8 H15 N O6) FORMUL 4 FUC 2(C6 H12 O5) FORMUL 5 BMA C6 H12 O6 FORMUL 5 MAN 2(C6 H12 O6) FORMUL 5 GAL C6 H12 O6 HELIX 1 1 GLY A 49 GLU A 54 5 6 HELIX 2 2 TRP A 59 ILE A 86 1 28 HELIX 3 3 TRP A 133 LYS A 145 1 13 HELIX 4 4 PRO A 147 THR A 159 1 13 HELIX 5 5 THR A 159 GLY A 172 1 14 HELIX 6 6 GLY A 172 GLU A 177 1 6 HELIX 7 7 ASP A 248 HIS A 250 5 3 HELIX 8 8 LYS C 246 MET C 252 1 7 HELIX 9 9 LEU C 309 ASP C 315 1 7 HELIX 10 10 SER C 354 MET C 358 5 5 HELIX 11 11 LYS C 414 GLN C 419 1 6 SHEET 1 A 8 ASP A 46 PRO A 47 0 SHEET 2 A 8 GLN A 33 ASN A 39 -1 N THR A 37 O ASP A 46 SHEET 3 A 8 PHE A 24 LEU A 30 -1 N ALA A 26 O TYR A 38 SHEET 4 A 8 LEU A 7 VAL A 14 -1 O MET A 8 N TRP A 29 SHEET 5 A 8 THR A 91 LEU A 100 -1 N LEU A 92 O ALA A 13 SHEET 6 A 8 SER A 106 LEU A 114 -1 O LEU A 107 N GLU A 99 SHEET 7 A 8 GLU A 117 PHE A 122 -1 O GLU A 117 N LEU A 114 SHEET 8 A 8 TRP A 129 GLY A 131 -1 N SER A 130 O ARG A 121 SHEET 1 B 4 SER A 183 PRO A 190 0 SHEET 2 B 4 SER A 195 PHE A 205 -1 N VAL A 197 O ARG A 189 SHEET 3 B 4 PHE A 236 LYS A 245 -1 N PHE A 236 O PHE A 205 SHEET 4 B 4 ASN A 225 PRO A 230 -1 N ASN A 225 O LEU A 241 SHEET 1 C 4 LEU A 219 ALA A 220 0 SHEET 2 C 4 LYS A 211 ARG A 216 -1 N ARG A 216 O LEU A 219 SHEET 3 C 4 TYR A 252 GLU A 257 -1 O GLN A 253 N LEU A 215 SHEET 4 C 4 LEU A 265 VAL A 267 -1 N LEU A 265 O VAL A 256 SHEET 1 D 4 GLN B 6 SER B 11 0 SHEET 2 D 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 D 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 D 4 GLU B 50 MET B 51 -1 N GLU B 50 O HIS B 67 SHEET 1 E 4 GLN B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 E 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 F 4 LYS B 44 LYS B 45 0 SHEET 2 F 4 GLU B 36 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 F 4 TYR B 78 LYS B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 F 4 LYS B 91 THR B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 G 4 VAL C 240 PHE C 243 0 SHEET 2 G 4 GLU C 258 ASP C 265 -1 O THR C 260 N PHE C 243 SHEET 3 G 4 TYR C 300 THR C 307 -1 O TYR C 300 N ASP C 265 SHEET 4 G 4 ARG C 292 GLN C 295 -1 N ARG C 292 O VAL C 303 SHEET 1 H 4 VAL C 282 GLN C 283 0 SHEET 2 H 4 PHE C 275 VAL C 279 -1 N VAL C 279 O VAL C 282 SHEET 3 H 4 TYR C 319 VAL C 323 -1 N LYS C 320 O TYR C 278 SHEET 4 H 4 ILE C 332 ILE C 336 -1 O ILE C 332 N VAL C 323 SHEET 1 I 4 GLN C 347 LEU C 351 0 SHEET 2 I 4 GLN C 362 PHE C 372 -1 O THR C 366 N LEU C 351 SHEET 3 I 4 PHE C 404 ASP C 413 -1 N PHE C 404 O PHE C 372 SHEET 4 I 4 TYR C 391 THR C 393 -1 O LYS C 392 N LYS C 409 SHEET 1 J 4 GLN C 347 LEU C 351 0 SHEET 2 J 4 GLN C 362 PHE C 372 -1 O THR C 366 N LEU C 351 SHEET 3 J 4 PHE C 404 ASP C 413 -1 N PHE C 404 O PHE C 372 SHEET 4 J 4 VAL C 397 LEU C 398 -1 N VAL C 397 O PHE C 405 SHEET 1 K 4 GLN C 386 PRO C 387 0 SHEET 2 K 4 ALA C 378 SER C 383 -1 N SER C 383 O GLN C 386 SHEET 3 K 4 PHE C 423 MET C 428 -1 O SER C 424 N GLU C 382 SHEET 4 K 4 THR C 437 LEU C 441 -1 N THR C 437 O VAL C 427 SSBOND 1 CYS A 98 CYS A 161 1555 1555 2.03 SSBOND 2 CYS A 200 CYS A 254 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS C 261 CYS C 321 1555 1555 2.06 SSBOND 5 CYS C 367 CYS C 425 1555 1555 2.03 LINK ND2 ASN A 104 C1 NAG A 401 1555 1555 1.46 LINK N SER A 193 O7 NAG D 1 6755 1555 1.17 LINK ND2 ASN A 225 C1 NAG D 1 1555 1555 1.46 LINK ND2 ASN C 297 C1 NAG E 1 1555 1555 1.47 LINK O6 NAG D 1 C1 FUC D 2 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O6 NAG E 1 C1 FUC E 9 1555 1555 1.43 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.43 LINK O6 BMA E 3 C1 MAN E 4 1555 1555 1.43 LINK O3 BMA E 3 C1 MAN E 7 1555 1555 1.43 LINK O2 MAN E 4 C1 NAG E 5 1555 1555 1.43 LINK O4 NAG E 5 C1 GAL E 6 1555 1555 1.44 LINK O2 MAN E 7 C1 NAG E 8 1555 1555 1.43 CISPEP 1 TYR A 206 PRO A 207 0 -1.09 CISPEP 2 HIS B 31 PRO B 32 0 0.42 CISPEP 3 TYR C 373 PRO C 374 0 -5.15 SITE 1 B1A 24 ASN A 84 GLN A 85 ILE A 86 PHE A 90 SITE 2 B1A 24 ALA A 113 LEU A 114 ASN A 115 GLY A 116 SITE 3 B1A 24 GLU A 117 GLU A 118 PHE A 119 GLY A 131 SITE 4 B1A 24 GLU A 132 TRP A 133 PRO A 134 GLU A 135 SITE 5 B1A 24 THR A 136 ASP A 137 ILE B 1 GLN B 2 SITE 6 B1A 24 LYS B 3 THR B 4 THR B 86 LYS B 88 SITE 1 B2A 2 LEU A 219 LYS A 245 SITE 1 B1B 25 LYS C 248 THR C 250 LEU C 251 MET C 252 SITE 2 B1B 25 ILE C 253 SER C 254 ARG C 255 THR C 256 SITE 3 B1B 25 PRO C 257 LYS C 288 LYS C 290 PRO C 291 SITE 4 B1B 25 VAL C 308 LEU C 309 HIS C 310 GLN C 311 SITE 5 B1B 25 LEU C 314 GLY C 385 GLN C 386 PRO C 387 SITE 6 B1B 25 MET C 428 HIS C 433 ASN C 434 HIS C 435 SITE 7 B1B 25 TYR C 436 SITE 1 B2B 2 GLN C 272 HIS C 285 CRYST1 125.000 145.000 216.500 90.00 90.00 90.00 I 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006897 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004619 0.00000